by McKesson Ventures | Jun 13, 2023 | Press Releases
Koneksa has announced a partnership with Beacon Biosignals, a computational neurodiagnostics company, to launch a clinical trial to investigate the integration of Beacon’s at-home electroencephalogram (EEG) into the Koneksa Neuroscience Solution Toolkit. The Beacon...
by McKesson Ventures | Mar 16, 2022 | Portfolio News
Koneksa Health Chief Medical Officer John A. Wagner, MD, Ph.D., recently gave a video presentation titled “Multi-Component Biomarkers: Promise, Practice and Perspective on Terminology,” which was uploaded to the U.S. Food and Drug Administration’s YouTube channel. Dr....
by McKesson Ventures | Feb 7, 2022 | Press Releases
Digital biomarker design and validation company Koneksa recently announced that it had completed a Series C funding round in which it raised $45 million. The funding round was led by AyurMaya, with Velosity Capital and Takeda Ventures participating as well. Existing...
by McKesson Ventures | Nov 3, 2021 | Press Releases
Digital Biomarker company Koneksa announced an extension to its collaboration with Sanofi in central nervous system clinical trials. Sanofi is one of the world’s top biopharmaceutical companies, and Koneksa CEO Chris Benko expressed enthusiasm for the extension:...
by McKesson Ventures | Mar 15, 2021 | Portfolio News
The use of wearables has been of great benefit to clinical trials: researchers can gather far more data, more often, more objectively, and more easily than ever before. And over the past year, digital tools for remote measurement made it possible to continue trials...
